Results 91 to 100 of about 297 (139)

The SChISM study: Circulating cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors

open access: yes
BackgroundCirculating cell-free DNA (cfDNA) offers a promising noninvasive way to predict resistance to immune-checkpoint inhibitors (ICI), for which robust biomarkers are still lacking.MethodsThe SChISM (Size CfDNA Immunotherapy Signature Monitoring ...
Boutonnet, Audrey   +11 more
core   +3 more sources

DNAviWEB: sequencing-free clinical screening of liquid biopsies. [PDF]

open access: yesNucleic Acids Res
Hess A, Matani Y, Seelow D, Kretzmer H.
europepmc   +1 more source

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors. [PDF]

open access: yesClin Cancer Res
Canzoniero JV   +24 more
europepmc   +1 more source

Sinteza nove piridinijeve soli s triazolilidenskim fragmentom

open access: yes, 2020
This thesis describes the synthesis of a novel pyridinium salt bearing triazolylidene fragment bounded to pyridine nitrogen atom, which has not yet been described in the literature. The synthesized salt represents a potential bidentate dicarbene NHC ligand, useful for the formation of transition metal NHC complexes.
openaire   +1 more source

Cancer in a Drop: Liquid biopsy insights from AACR 2025. [PDF]

open access: yesJ Liq Biopsy
Maheswaran S   +7 more
europepmc   +1 more source

Liquid biopsies for early detection of gliomas: are we near a breakthrough? [PDF]

open access: yesAnn Med Surg (Lond)
Amjad A, Ali MR, Khalid M, Segawa F.
europepmc   +1 more source

Characterization of global cfDNA fragmentomics in Melanoma Patients

open access: yesEJC Skin Cancer
J.L. Villanueva-Cañas   +8 more
openaire   +1 more source

Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions. [PDF]

open access: yesFront Med (Lausanne)
Thalambedu N   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy